HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Monika Pema Selected Research

Phosphotransferases (Kinase)

4/2017Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Monika Pema Research Topics

Disease

2Autosomal Dominant Polycystic Kidney (ADPKD)
04/2017 - 04/2013
2Cysts
04/2016 - 03/2016
2Polycystic Kidney Diseases (Polycystic Kidney Disease)
03/2016 - 04/2013
1Renal Cell Carcinoma (Grawitz Tumor)
01/2018
1Carcinogenesis
01/2018
1Ischemia
04/2016
1Cystic Kidney Diseases (Cystic Kidney Disease)
04/2016
1Tuberous Sclerosis (Bourneville's Disease)
03/2016

Drug/Important Bio-Agent (IBA)

2Sirolimus (Rapamycin)FDA Link
04/2017 - 03/2016
1Mechanistic Target of Rapamycin Complex 1IBA
01/2018
1FumaratesIBA
01/2018
1N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA
04/2017
1Phosphotransferases (Kinase)IBA
04/2017
1polycystic kidney disease 1 proteinIBA
04/2016
1EnzymesIBA
04/2016
1Phosphatidylinositols (Phosphatidylinositol)IBA
04/2016
1trans-sodium crocetinate (crocetin)IBA
03/2016
1Glucose (Dextrose)FDA LinkGeneric
04/2013

Therapy/Procedure

2Therapeutics
04/2017 - 04/2013